Madrigal Pharmaceuticals, Inc.MDGLNASDAQ
Loading
EPS Growth AcceleratingAccelerating
Percentile Rank86
Studio
Year-over-Year Change

Year-over-year earnings per share growth rate

Latest
41.32%
↑ 390% vs avg
Percentile
P86
Within normal range
Streak
3 yr
Consecutive growthAccelerating
Average
-14.24%
Historical baseline
PeriodValue
202541.32%
2024-9.55%
2023-16.02%
2022-17.77%
2021-11.76%
2020-176.74%
2019-113.06%
201812.60%
201749.90%
201698.74%